<PAPER>
  <mode2 name="ehp19_arathi" hasDoc="yes" version="1258"/>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
    <front>
      <journal-meta>
        <journal-id journal-id-type="publisher-id">EHP</journal-id>
        <journal-id journal-id-type="nlm-ta">Environ Health Perspect</journal-id>
        <journal-title>Environmental Health Perspectives</journal-title>
        <abbrev-journal-title abbrev-type="pubmed">Environ. Health Perspect.</abbrev-journal-title>
        <issn pub-type="epub">0091-6765</issn>
        <publisher>
          <publisher-name>National Institute of Environmental Health Sciences</publisher-name>
        </publisher>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="publisher-id">ehp.7143</article-id>
        <article-id pub-id-type="doi">10.1289/ehp.7143</article-id>
        <title-group>
          <article-title>
            <s sid="1">Organochlorine Exposure and Colorectal Cancer Risk<CoreSc1 atype="GSC" type="Obj" conceptID="Obj1" novelty="None" advantage="None"/></s>
          </article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Howsam</surname>
              <given-names>Mike</given-names>
            </name>
            <xref ref-type="aff" rid="aff1">
              <sup>1</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Grimalt</surname>
              <given-names>Joan O.</given-names>
            </name>
            <xref ref-type="aff" rid="aff2">
              <sup>2</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Guin&#243;</surname>
              <given-names>Elisabet</given-names>
            </name>
            <xref ref-type="aff" rid="aff3">
              <sup>3</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Navarro</surname>
              <given-names>Matilde</given-names>
            </name>
            <xref ref-type="aff" rid="aff3">
              <sup>3</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Mart&#237;-Ragu&#233;</surname>
              <given-names>Juan</given-names>
            </name>
            <xref ref-type="aff" rid="aff4">
              <sup>4</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Peinado</surname>
              <given-names>Miguel A.</given-names>
            </name>
            <xref ref-type="aff" rid="aff5">
              <sup>5</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Capell&#225;</surname>
              <given-names>Gabriel</given-names>
            </name>
            <xref ref-type="aff" rid="aff3">
              <sup>3</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" corresp="yes" xlink:type="simple">
            <name name-style="western">
              <surname>Moreno</surname>
              <given-names>Victor</given-names>
            </name>
            <xref ref-type="aff" rid="aff3">
              <sup>3</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" corresp="yes" xlink:type="simple">
            <collab xlink:type="simple">for the Bellvitge Colorectal Cancer Group</collab>
          </contrib>
          <xref ref-type="fn" rid="afn1">*</xref>
          <aff id="aff1">
            <label>1</label>
            <addr-line>Laboratoire Universitaire de M&#233;d&#233;cine du Travail, Lille, France</addr-line>
          </aff>
          <aff id="aff2">
            <label>2</label>
            <addr-line>Consejo Superior de Investigaciones Cientificas, Department of Environmental Chemistry, Institute of Chemical and Environmental Research, Barcelona, Catalonia, Spain</addr-line>
          </aff>
          <aff id="aff3">
            <label>3</label>
            <addr-line>Catalan Institute of Oncology, Barcelona, Catalonia, Spain</addr-line>
          </aff>
          <aff id="aff4">
            <label>4</label>
            <addr-line>Ciudad Sanitaria i Universitaria de Bellvitge, University of Barcelona, Barcelona, Catalonia, Spain</addr-line>
          </aff>
          <aff id="aff5">
            <label>5</label>
            <addr-line>Oncology Research Institute, Barcelona, Catalonia, Spain</addr-line>
          </aff>
        </contrib-group>
        <author-notes>
          <corresp id="cor1">Address correspondence to V. Moreno, Servei d'Epidemiologia i Registre del Cancer, Institut Catala d'Oncologia, Gran Via km 2.7, L'Hospitalet, 08907 Barcelona, Catalonia, Spain. Telephone: 34-93-260-7812; Fax: 34-93-260-7787. E-mail: <email xlink:type="simple">v.moreno@iconcologia.catsalut.net</email></corresp>
          <fn id="afn1">
            <label>*</label>
            <p>Members of the Bellvitge Colorectal Cancer Study Group: Victor Moreno, Matilde Navarro, Joan Mart&#237;-Ragu&#233;, Javier de Oca, Alfonso Osorio, Carlos del R&#237;o, Sebastiano Biondo, Josep M&#170; Badosa, Mar&#237;a Cambray, Felip Vilardell, Bel&#233;n Lloveras, Valeri Novell, Elisabet Guin&#243;, Laura Pareja, Miguel A. Peinado, and Gabriel Capell&#225;.</p>
          </fn>
        </author-notes>
        <pub-date pub-type="epub">
          <day>15</day>
          <month>07</month>
          <year>2004</year>
        </pub-date>
        <volume>112</volume>
        <issue>15</issue>
        <fpage>1460</fpage>
        <lpage>1466</lpage>
        <history>
          <date date-type="received">
            <day>01</day>
            <month>04</month>
            <year>2004</year>
          </date>
          <date date-type="accepted">
            <day>14</day>
            <month>07</month>
            <year>2004</year>
          </date>
        </history>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/" xlink:type="simple">
          <p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
        </license>
        <permissions>
          <copyright-year>2004</copyright-year>
          <copyright-holder/>
        </permissions>
        <abstract>
          <p>
            <s sid="2">Organochlorine compounds have been linked to increased risk of several cancers.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/></s>
            <s sid="3">Despite reductions in their use and fugitive release, they remain one of the most important groups of persistent pollutants to which humans are exposed, primarily through dietary intake.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/></s>
            <s sid="4">We designed a case-control study to assess the risk of colorectal cancer with exposure to these chemicals, and their potential interactions with genetic alterations in the tumors.<CoreSc1 atype="GSC" type="Goa" conceptID="Goa1" novelty="None" advantage="None"/></s>
            <s sid="5">A subsample of cases (<italic>n</italic> = 132) and hospital controls (<italic>n</italic> = 76) was selected from a larger case-control study in Barcelona, Catalonia, Spain.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp1" novelty="None" advantage="None"/></s>
            <s sid="6">We measured concentrations in serum of several organochlorines by gas chromatography.<CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="None" advantage="None"/></s>
            <s sid="7">We assessed point mutations in K-<italic>ras</italic> and <italic>p53</italic> genes in tissue samples by polymerase chain reaction/single-strand conformation polymorphism and assessed expression of p53 protein by immunohistochemical methods.<CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="None" advantage="None"/></s>
            <s sid="8">An elevated risk of colorectal cancer was associated with higher serum concentrations of mono-<italic>ortho</italic> polychlorinated biphenyl (PCB) congeners 28 and 118.<CoreSc1 atype="GSC" type="Res" conceptID="Res1" novelty="None" advantage="None"/></s>
            <s sid="9">The odds ratio for these mono-<italic>ortho</italic> PCBs for middle and higher tertile were, respectively, 1.82 [95% confidence interval (CI), 0.90-3.70] and 2.94 (95% CI, 1.39-6.20).<CoreSc1 atype="GSC" type="Res" conceptID="Res2" novelty="None" advantage="None"/></s>
            <s sid="10">&#593;-Hexachlorocyclohexane, hexachlorobenzene, and <italic>p</italic>,<italic>p</italic>&#180;-DDE (4,4&#180;-dichlorodiphenyltrichloroethene) showed nonsignificant increases in risk.<CoreSc1 atype="GSC" type="Res" conceptID="Res3" novelty="None" advantage="None"/></s>
            <s sid="11">Risk associated with mono-<italic>ortho</italic> PCBs was slightly higher for tumors with mutations in the <italic>p53</italic> gene but was not modified by mutations in K-<italic>ras</italic>.<CoreSc1 atype="GSC" type="Res" conceptID="Res4" novelty="None" advantage="None"/></s>
            <s sid="12">Mono-<italic>ortho</italic> PCBs were further associated with transversion-type mutations in both genes.<CoreSc1 atype="GSC" type="Res" conceptID="Res5" novelty="None" advantage="None"/></s>
            <s sid="13">These results generate the hypothesis that exposure to mono-<italic>ortho</italic> PCBs contributes to human colorectal cancer development.<CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/></s>
            <s sid="14">The trend and magnitude of the association, as well as the observation of a molecular fingerprint in tumors, raise the possibility that this finding may be causal.<CoreSc1 atype="GSC" type="Con" conceptID="Con2" novelty="None" advantage="None"/></s>
          </p>
        </abstract>
        <kwd-group kwd-group-type="author" xml:lang="EN">
          <kwd>case-control study</kwd>
          <kwd>colorectal cancer</kwd>
          <kwd>K-<italic>ras</italic> mutations</kwd>
          <kwd>organochlorines</kwd>
          <kwd><italic>p53</italic> mutations</kwd>
          <kwd>PCBs</kwd>
        </kwd-group>
      </article-meta>
    </front>
    <body>
      <p>
        <s sid="15">Colorectal cancer is the third most common human cancer and the second most important cause of cancer-related death in Western countries, affecting men and women about equally.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj2" novelty="None" advantage="None"/></s>
        <s sid="16">The etiology of sporadic colorectal cancer is relatively poorly understood, although diet is thought to play an important role in modifying risk.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/></s>
        <s sid="17">Vegetables, fruit, and dietary fiber are protective, whereas red and processed meats, fat, total energy intake, and obesity all increase risk (<xref ref-type="bibr" rid="r34">Potter 1996</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac4" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="18">Diet is also an important source of exposure to many synthetic organic chemicals used in industry, agriculture, or accidentally released to the environment.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/></s>
        <s sid="19">Among them, the industrial organochlorine compounds (OCs) hexachlorobenzene (HCB) and polychlorinated biphenyls (PCBs) and the pesticides DDT (dichlorodiphenyltrichloroethane) and lindane [ &#611;-hexachlorocyclohexane (HCH), including &#593;-HCH and &#223;-HCH isomers] have been classified as "probably" or "possibly" carcinogenic to humans [International Agency for Research on Cancer (IARC) 1987, 1991].<CoreSc1 atype="GSC" type="Bac" conceptID="Bac6" novelty="None" advantage="None"/></s>
        <s sid="20">Most of the data for these classifications come from animal studies, although evidence for carcinogenic effects in humans is accumulating from occupational and nonoccupational exposure studies [Agency for Toxic Substances and Disease Registry (ATSDR) 2000, 2002].<CoreSc1 atype="GSC" type="Bac" conceptID="Bac7" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="21">Despite reductions in their use and fugitive release, OCs remain one of the most important groups of persistent pollutants to which humans are exposed, primarily via dietary intake.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac8" novelty="None" advantage="None"/></s>
        <s sid="22">More lipophilic OCs, and those that are not easily metabolized, accumulate in adipose tissue, and the half-lives of these compounds in the body can be on the order of years or decades, whereas those compounds that are more water soluble or more easily metabolized have half-lives on the order of hours or days.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac9" novelty="None" advantage="None"/></s>
        <s sid="23">Eventually, OCs recirculate in blood and are excreted in feces (<xref ref-type="bibr" rid="r31">Moser and McLachlan 2001</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac10" novelty="None" advantage="None"/></s>
        <s sid="24">Serum concentrations are strongly correlated with fecal concentrations, particularly for the more lipophilic compounds that accumulate in adipose tissue and are generally more chlorinated (<xref ref-type="bibr" rid="r25">Juan et al. 2002</xref>; <xref ref-type="bibr" rid="r31">Moser and McLachlan 2001</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac11" novelty="None" advantage="None"/></s>
        <s sid="25">Exposure of tissue in the gastrointestinal tract to OCs is the result, therefore, not only of uptake from food but also of depuration from the tissue to the lumen.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac12" novelty="None" advantage="None"/></s>
        <s sid="26">The long residence time (1-2 days) of feces in the colon offers potentially greater opportunity for exchange of OCs between the lumen and the epithelium than elsewhere in the gastrointestinal tract.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac13" novelty="None" advantage="None"/></s>
        <s sid="27">However, the physicochemical characteristics of the compound (specifically, its solubility in water) will be more important in determining the relative importance of these exchange processes in the colon than in the small intestine, given the predominantly aqueous nature of the colonic milieu (<xref ref-type="bibr" rid="r31">Moser and McLachlan 2001</xref>; <xref ref-type="bibr" rid="r38">Schlummer et al. 1998</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac14" novelty="None" advantage="None"/></s>
        <s sid="28">Therefore, colon epithelium is likely to be a major target for putative carcinogenic effects of OCs via luminal and blood-borne exposure.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac15" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="29">OCs have been shown to mimic hormones, and this has been postulated as a mechanism for carcinogenesis in hormone-dependent cancers (<xref ref-type="bibr" rid="r14">Davis et al. 1993</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac16" novelty="None" advantage="None"/></s>
        <s sid="30">Although colorectal cancer cannot be considered a hormone-dependent cancer, there is evidence that hormones play a role, at least in women: hormone replacement therapy and, possibly, high parity and oral contraceptive use are all protective factors (<xref ref-type="bibr" rid="r35">Potter 1999</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac17" novelty="None" advantage="None"/></s>
        <s sid="31">Studies of cancers of the pancreas and breast have shown that OCs may interact with genetic alterations in tumors such as K-<italic>ras</italic> mutations or p53 overexpression (<xref ref-type="bibr" rid="r22">Hoyer et al. 2002</xref>; <xref ref-type="bibr" rid="r33">Porta et al. 1999</xref>; <xref ref-type="bibr" rid="r40">Slebos et al. 2000</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac18" novelty="None" advantage="None"/></s>
        <s sid="32">Research on these interactions is relevant because they are frequent in colorectal cancer, and one potential mechanism of OC toxicity may be the induction of mutations in these genes.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac19" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="33">Despite this, few studies of OC exposure and colorectal cancer risk have been published.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot1" novelty="None" advantage="None"/></s>
        <s sid="34">Some studies in occupationally exposed cohorts have shown mixed results (<xref ref-type="bibr" rid="r1">Acquavella et al. 1996</xref>; <xref ref-type="bibr" rid="r7">Bertazzi et al. 1987</xref>; <xref ref-type="bibr" rid="r9">Brown 1987</xref>; <xref ref-type="bibr" rid="r12">Cantor and Silberman 1999</xref>; <xref ref-type="bibr" rid="r27">Leet et al. 1996</xref>; <xref ref-type="bibr" rid="r45">Wilkinson et al. 1997</xref>), whereas studies with data on individual plasma levels are rare.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac20" novelty="None" advantage="None"/></s>
        <s sid="35">One study of colorectal cancer in children from rural areas exposed to pesticides showed no differences in serum OC levels compared with controls (<xref ref-type="bibr" rid="r10">Caldwell et al. 1981</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac21" novelty="None" advantage="None"/></s>
        <s sid="36">Higher (nonsignificant) serum concentrations of DDT and &#223;-HCH in cases than in controls were reported in a small study of farmers in Egypt (<xref ref-type="bibr" rid="r41">Soliman et al. 1997</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac22" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="37">To test the hypothesis that exposure to OCs plays an etiologic role in colorectal cancer, we determined serum concentrations in a subset of samples from a hospital-based case-control study.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp1" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Goa" conceptID="Goa2" novelty="None" advantage="None"/></s>
        <s sid="38">In addition, we investigated the relationship between OC concentrations and mutations of the K-<italic>ras</italic> and <italic>p53</italic> genes.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj3" novelty="None" advantage="None"/></s>
      </p>
      <sec sec-type="materials|methods">
        <title>Materials and Methods</title>
        <p>
          <s sid="39"><bold><italic>Study population.</italic></bold> We conducted a hospital-based case-control study to assess gene-environment interactions in relation to colorectal cancer risk.<CoreSc1 atype="GSC" type="Met" conceptID="Met3" novelty="None" advantage="None"/></s>
          <s sid="40">A detailed description of the population and study methods has already been published (<xref ref-type="bibr" rid="r26">Landi et al. 2003</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met4" novelty="None" advantage="None"/></s>
          <s sid="41">Cases were patients with a new diagnosis of colorectal adenocarcinoma attending a university hospital in Barcelona, Catalonia, Spain, between January 1996 and December 1998.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp2" novelty="None" advantage="None"/></s>
          <s sid="42">Controls were selected from admissions to the same hospital during this period using age and sex as frequency-matching criteria.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp3" novelty="None" advantage="None"/></s>
          <s sid="43">To avoid selection bias of controls, the reason for admission had to be a disease not previously diagnosed for that patient.<CoreSc1 atype="GSC" type="Met" conceptID="Met5" novelty="None" advantage="None"/></s>
          <s sid="44">This criterion was used to avoid inclusion of patients with chronic diseases who might be repeatedly admitted to hospital and modify their habits because of their disease.<CoreSc1 atype="GSC" type="Met" conceptID="Met6" novelty="None" advantage="None"/></s>
          <s sid="45">This procedure paralleled the criterion for cases, who were also newly diagnosed incident cases.<CoreSc1 atype="GSC" type="Met" conceptID="Met7" novelty="None" advantage="None"/></s>
          <s sid="46">Main diagnosis groups of controls were acute digestive surgery (19%), urology (17%), gastroenterology (16%), and orthopedic surgery (15%).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp4" novelty="None" advantage="None"/></s>
          <s sid="47">The study protocol was cleared by the ethics committee of the hospital, and all individuals gave written, informed consent to participate and for genetic analysis of their samples to be performed.<CoreSc1 atype="GSC" type="Met" conceptID="Met8" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="48">Of 523 identified cases, there were 13 (2%) refusals and 74 (14%) exclusions, with reasons including mental or other impairment and death or discharge before recruitment.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp5" novelty="None" advantage="None"/></s>
          <s sid="49">We identified a total of 488 controls, with 36 (7%) refusals and 22 (5%) exclusions (reasons as described above).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp6" novelty="None" advantage="None"/></s>
          <s sid="50">From these 436 cases and 430 controls, we selected a random sample of 140 cases and 80 controls for OC analyses for budgetary reasons.<CoreSc1 atype="GSC" type="Met" conceptID="Met9" novelty="None" advantage="None"/></s>
          <s sid="51">The sample size and imbalance in number between cases and controls was chosen to retain statistical power for our study of K-<italic>ras</italic> and <italic>p53</italic> mutations among cases [80% power to detect odds ratios (ORs) of 2.25 for the exposures of interest].<CoreSc1 atype="GSC" type="Met" conceptID="Met10" novelty="None" advantage="None"/></s>
          <s sid="52">Controls for this study were selected using strata based on age, sex, and energy intake, the latter being used as a frequency-matching criterion because diet is a main source of exposure to OCs.<CoreSc1 atype="GSC" type="Met" conceptID="Met11" novelty="None" advantage="None"/></s>
          <s sid="53">Twelve samples were lost or excluded because of bad quality during laboratory analyses, and statistical tests were conducted on 132 cases and 76 controls.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp7" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="54"><bold><italic>Interviews.</italic></bold> Cases and controls were interviewed by trained personnel using a structured questionnaire.<CoreSc1 atype="GSC" type="Met" conceptID="Met12" novelty="None" advantage="None"/></s>
          <s sid="55">A dietary history questionnaire, previously developed and validated in the framework of the EPIC study [European Prospective Investigation into Cancer and Nutrition (EPIC) Group of Spain 1997], focused on average food consumption 1 year before diagnosis.<CoreSc1 atype="GSC" type="Met" conceptID="Met13" novelty="None" advantage="None"/></s>
          <s sid="56">Food groups based on bromatologic properties were calculated from reports of items consumed.<CoreSc1 atype="GSC" type="Met" conceptID="Met14" novelty="None" advantage="None"/></s>
          <s sid="57">Other risk factors measured were body mass index (BMI) at diagnosis and 10 years before, parity in women, and life-long history of nonsteroidal anti-inflammatory drugs (NSAIDs), tobacco, and alcohol use.<CoreSc1 atype="GSC" type="Met" conceptID="Met15" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="58"><bold><italic>Organochlorine analysis.</italic></bold> Selection of OCs for analysis was based on a literature search of commonly studied contaminants and included representatives of industrial and agrochemical compounds.<CoreSc1 atype="GSC" type="Met" conceptID="Met16" novelty="None" advantage="None"/></s>
          <s sid="59">Among the large family of PCB congeners, those often referred to as the ICES 7 (from International Council for the Exploration of the Sea), were selected: mono-<italic>ortho</italic> PCB congeners 28 and 118 and di-<italic>ortho</italic> PCBs 52, 101, 138, 153, 180.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/></s>
          <s sid="60">These PCB congeners are frequently found at high concentrations in humans and wildlife.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac23" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="61">Nonfasting blood samples were obtained at diagnosis, and serum was isolated and analyzed "blind" for OCs.<CoreSc1 atype="GSC" type="Met" conceptID="Met17" novelty="None" advantage="None"/></s>
          <s sid="62">We calculated lipid-corrected concentrations of OCs by dividing serum OC concentrations by total plasma lipid concentrations estimated using the formula of <xref ref-type="bibr" rid="r32">Phillips et al. (1989)</xref>, and data are expressed in nanograms of OC per gram of lipid.<CoreSc1 atype="GSC" type="Met" conceptID="Met18" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="63">OCs were analyzed by gas chromatography after serum samples were subjected to liquid-liquid extraction and cleanup using concentrated sulfuric acid and hexane (<xref ref-type="bibr" rid="r33">Porta et al. 1999</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met19" novelty="None" advantage="None"/></s>
          <s sid="64">A mass spectrometer in negative chemical ionization mode was used to quantify &#593;-, &#223;-, &#611;-, and &#397;-HCH isomers; pentachlorobenzene (Pe-CB), HCB, PCB congeners, <italic>p</italic>,<italic>p</italic>&#180;-DDT, and <italic>p</italic>,<italic>p</italic>&#180;-DDE (4,4&#180;-dichlorodiphenyltrichloroethene) were quantified on a gas chromatograph with electron capture detection.<CoreSc1 atype="GSC" type="Met" conceptID="Met20" novelty="None" advantage="None"/></s>
          <s sid="65">On both instruments, quantification was performed by external standards using PCB-142 as an injection standard to correct for volume.<CoreSc1 atype="GSC" type="Met" conceptID="Met21" novelty="None" advantage="None"/></s>
          <s sid="66">This method performed satisfactorily in an international intercalibration exercise within the Arctic Monitoring and Assessment Programme (<xref ref-type="bibr" rid="r3">AMAP 2004</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met22" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="67"><bold><italic>Point mutations in K-</italic>ras <italic>and</italic> p53 <italic>genes, and expression of p53 protein.</italic></bold> Fresh tumor tissue and normal mucosa samples were obtained from surgically extracted specimens of cases.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/></s>
          <s sid="68">K-<italic>ras</italic> gene mutations in codons 12 and 13 were detected and characterized by polymerase chain reaction (PCR) followed by single-strand conformation polymorphism (SSCP) analysis (<xref ref-type="bibr" rid="r42">Tortola et al. 1999</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met23" novelty="None" advantage="None"/></s>
          <s sid="69">Aspartic acid mutations at codons 12 and 13 were confirmed by means of artificially introduced restriction fragment length polymorphism.<CoreSc1 atype="GSC" type="Met" conceptID="Met24" novelty="None" advantage="None"/></s>
          <s sid="70">Similarly, <italic>p53</italic> exons 4-9 were analyzed by PCR and SSCP followed by direct sequencing whenever necessary.<CoreSc1 atype="GSC" type="Met" conceptID="Met25" novelty="None" advantage="None"/></s>
          <s sid="71">Expression of the p53 protein was determined by immunohistochemistry, using commercially available antibodies (ab-6 Pantropic; Oncogene Research Products, VWR International GmBH, Darmstadt, Germany).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp10" novelty="None" advantage="None"/></s>
          <s sid="72">We studied microsatellite instability by analyzing five microsatellite sequences (<xref ref-type="bibr" rid="r18">Gonzalez-Garcia et al. 2000</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met26" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="73"><bold><italic>Statistical analysis.</italic></bold> OC concentrations were categorized using tertiles based on all subjects.<CoreSc1 atype="GSC" type="Met" conceptID="Met27" novelty="None" advantage="None"/></s>
          <s sid="74">Some compounds were not detected in a high proportion of individuals.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs1" novelty="None" advantage="None"/></s>
          <s sid="75">For these, the reference category consisted of values below the detection limit (LOD).<CoreSc1 atype="GSC" type="Met" conceptID="Met28" novelty="None" advantage="None"/></s>
          <s sid="76">When the proportion of individuals with detectable values was &gt; 50%, the values were further divided into two groups using the median value of those with values &gt; LOD.<CoreSc1 atype="GSC" type="Met" conceptID="Met29" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="77">Logistic regression was used to test the association between OCs and colorectal cancer.<CoreSc1 atype="GSC" type="Met" conceptID="Met30" novelty="None" advantage="None"/></s>
          <s sid="78">When cases were subdivided into groups according to genetic alterations, we used polytomous logistic regression, comparing each group of cases with the whole set of controls.<CoreSc1 atype="GSC" type="Met" conceptID="Met31" novelty="None" advantage="None"/></s>
          <s sid="79">All analyses were adjusted for age, sex, total energy intake, and BMI at diagnosis because these had been used as frequency-matching criteria or, in case of BMI, because of concerns about potential confounding of OC exposure by BMI, given that cases showing lower BMI might have undergone lipid-stored OC mobilization.<CoreSc1 atype="GSC" type="Met" conceptID="Met32" novelty="None" advantage="None"/></s>
          <s sid="80">The impact of these adjustments on risk estimates was minimal, however.<CoreSc1 atype="GSC" type="Met" conceptID="Met33" novelty="None" advantage="None"/></s>
          <s sid="81">We also excluded an association between OCs and tumor stage that would be indicative of bias, because more advanced tumors are associated with greater weight loss.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/></s>
          <s sid="82">Potential confounding by other variables associated with disease (alcohol, NSAIDs, and food groups) was explored and rejected.<CoreSc1 atype="GSC" type="Met" conceptID="Met34" novelty="None" advantage="None"/></s>
          <s sid="83">These were not included in the models to avoid losing efficiency in the estimates owing to excessive stratification.<CoreSc1 atype="GSC" type="Met" conceptID="Met35" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="84">ORs and 95% confidence intervals (CIs) were calculated for each group compared with the reference category.<CoreSc1 atype="GSC" type="Met" conceptID="Met36" novelty="None" advantage="None"/></s>
          <s sid="85">We tested for linear trend using the categorized variable as quantitative after assigning codes 1 to 3 to each category defined by tertiles.<CoreSc1 atype="GSC" type="Met" conceptID="Met37" novelty="None" advantage="None"/></s>
          <s sid="86">Interactions between exposures and genetic alterations in tumors were tested with logistic regression models comparing cases with the alteration to cases without it.<CoreSc1 atype="GSC" type="Met" conceptID="Met38" novelty="None" advantage="None"/></s>
          <s sid="87">All <italic>p</italic>-values calculated were two sided.<CoreSc1 atype="GSC" type="Met" conceptID="Met39" novelty="None" advantage="None"/></s>
        </p>
      </sec>
      <sec sec-type="results">
        <title>Results</title>
        <p>
          <s sid="88">Characteristics of cases and controls are shown in <xref ref-type="table" rid="t1">Table 1</xref>.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs2" novelty="None" advantage="None"/></s>
          <s sid="89">Sex, age, and energy intake were used as frequency-matching criteria.<CoreSc1 atype="GSC" type="Met" conceptID="Met40" novelty="None" advantage="None"/></s>
          <s sid="90">BMI estimated 10 years before diagnosis was not related to disease.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs3" novelty="None" advantage="None"/></s>
          <s sid="91">In contrast, BMI at diagnosis was inversely related to disease, probably due to cancer-related weight loss, although no association was found between plasma lipids and disease, or between plasma lipids and OC concentrations.<CoreSc1 atype="GSC" type="Res" conceptID="Res6" novelty="None" advantage="None"/></s>
          <s sid="92">In this population, alcohol intake, but not smoking, was a strong risk factor for colorectal cancer, both in duration and in average daily consumption.<CoreSc1 atype="GSC" type="Res" conceptID="Res7" novelty="None" advantage="None"/></s>
          <s sid="93">NSAIDs other than aspirin were protective but not significantly so.<CoreSc1 atype="GSC" type="Res" conceptID="Res8" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="94"><bold><italic>OC levels.</italic></bold> Lipid-corrected concentrations of OCs are shown in <xref ref-type="table" rid="t2">Table 2</xref>.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs4" novelty="None" advantage="None"/></s>
          <s sid="95">The most abundant compound was <italic>p</italic>,<italic>p</italic>&#180;-DDE, followed by HCB and &#223;-HCH.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs5" novelty="None" advantage="None"/></s>
          <s sid="96">Summed PCB concentrations were similar to those of &#223;-HCH.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs6" novelty="None" advantage="None"/></s>
          <s sid="97">The proportions of samples with values lower than LODs are also shown in <xref ref-type="table" rid="t2">Table 2</xref>.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs7" novelty="None" advantage="None"/></s>
          <s sid="98">PCB-28 and PCB-52 were detected in only a small proportion of cases, although the LOD was very low.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs8" novelty="None" advantage="None"/></s>
          <s sid="99">These compounds are more easily metabolized than are other PCBs because of the arrangement of their chlorine atoms and their lower degree of chlorination (<xref ref-type="bibr" rid="r8">Borlakoglu and Walker 1989</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac24" novelty="None" advantage="None"/></s>
          <s sid="100">&#397;-HCH was not detected in any individual, and although Pe-CB and PCB-101 were detected in a few samples, their LODs were higher than other OCs; these three compounds were therefore excluded from statistical analyses.<CoreSc1 atype="GSC" type="Res" conceptID="Res9" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Obs" conceptID="Obs9" novelty="None" advantage="None"/></s>
        </p>
        <table-wrap id="t1" position="float">
          <label>Table 1</label>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.7143.t001" xlink:type="simple"/>
        </table-wrap>
        <table-wrap id="t2" position="float">
          <label>Table 2</label>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.7143.t002" xlink:type="simple"/>
        </table-wrap>
        <table-wrap id="t3" position="float">
          <label>Table 3</label>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.7143.t003" xlink:type="simple"/>
        </table-wrap>
        <table-wrap id="t4" position="float">
          <label>Table 4</label>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.7143.t004" xlink:type="simple"/>
        </table-wrap>
        <table-wrap id="t5" position="float">
          <label>Table 5</label>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.7143.t005" xlink:type="simple"/>
        </table-wrap>
        <table-wrap id="t6" position="float">
          <label>Table 6</label>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.7143.t006" xlink:type="simple"/>
        </table-wrap>
        <p>
          <s sid="101">Compounds were divided into two groups according to water solubility, and cases had slightly higher levels than did controls of both groups (data not shown).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs10" novelty="None" advantage="None"/></s>
          <s sid="102">PCBs were grouped according to their structure, which is related to toxicity (<xref ref-type="bibr" rid="r5">ATSDR 2000</xref>; <xref ref-type="bibr" rid="r37">Safe 1990</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac25" novelty="None" advantage="None"/></s>
          <s sid="103">Mono-<italic>ortho</italic> PCBs 28 and 118 have a relatively "planar" configuration compared with the remaining, di-<italic>ortho</italic> PCBs measured here.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac26" novelty="None" advantage="None"/></s>
          <s sid="104">Exposure to mono-<italic>ortho</italic> PCBs 28 and 118 was almost double in cases compared with controls, whereas exposure to di-<italic>ortho</italic> PCBs was only slightly higher for cases than for controls.<CoreSc1 atype="GSC" type="Res" conceptID="Res10" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="105"><bold><italic>OC levels and colorectal cancer risk.</italic></bold><xref ref-type="table" rid="t3">Table 3</xref> shows median lipid-corrected concentrations and 5th and 95th percentiles for each compound, separated for cases and controls.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs11" novelty="None" advantage="None"/></s>
          <s sid="106">ORs for the association of OCs with colorectal cancer, adjusted for age, sex, BMI, and energy intake, are shown in <xref ref-type="table" rid="t4">Table 4</xref>.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs12" novelty="None" advantage="None"/></s>
          <s sid="107">Those significantly associated with an increased risk were mono-<italic>ortho</italic> PCBs 28 and 118, each with individual ORs &gt; 2 for the more exposed category.<CoreSc1 atype="GSC" type="Res" conceptID="Res11" novelty="None" advantage="None"/></s>
          <s sid="108">The OR for serum concentrations of the mono-<italic>ortho</italic> PCB group that combines PCB-28 and PCB-118 was 1.82 (95% CI, 0.90-3.70) in the middle tertile (LOD, 147 ng/g lipid) and 2.94 (95% CI, 1.39-6.20; <italic>p</italic>-value for trend = 0.004) for the highest tertile.<CoreSc1 atype="GSC" type="Res" conceptID="Res12" novelty="None" advantage="None"/></s>
          <s sid="109">Concentrations of di-<italic>ortho</italic> PCBs were not related to disease, nor was the classification of OCs according to their lipophilicity.<CoreSc1 atype="GSC" type="Res" conceptID="Res13" novelty="None" advantage="None"/></s>
          <s sid="110">High levels of &#593;-HCH, HCB, and <italic>p</italic>,<italic>p</italic>&#180;-DDE showed a nonsignificant increase in risk.<CoreSc1 atype="GSC" type="Res" conceptID="Res14" novelty="None" advantage="None"/></s>
          <s sid="111">Levels of <italic>p</italic>,<italic>p</italic>&#180;-DDT were lower in cases than in controls in this population.<CoreSc1 atype="GSC" type="Res" conceptID="Res15" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="112"><bold><italic>OC levels and interaction with other variables.</italic></bold> Dietary variables, which are both sources of exposure and risk factors for colorectal cancer, were explored as potential confounders.<CoreSc1 atype="GSC" type="Met" conceptID="Met41" novelty="None" advantage="None"/></s>
          <s sid="113">Specific food groups explored were vegetables, fruit, legumes, potatoes, meat, fish, eggs, dairy products, added fats, and pastries.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/></s>
          <s sid="114">Spearman's correlation coefficients between food groups and serum levels of specific OCs were in general low and nonsignificant (maximum <italic>r</italic> = 0.19).<CoreSc1 atype="GSC" type="Res" conceptID="Res16" novelty="None" advantage="None"/></s>
          <s sid="115">Exceptions worth mentioning were dairy products, which correlated with <italic>p</italic>,<italic>p</italic>&#180;-DDT and PCB-101; fresh meats, which correlated with PCB-101, PCB-153, and PCB-180; and fish, which correlated with PCB-153 and PCB-180.<CoreSc1 atype="GSC" type="Res" conceptID="Res17" novelty="None" advantage="None"/></s>
          <s sid="116">The significance of these correlations was poor, and in addition to those correlations mentioned, we observed several negative correlations.<CoreSc1 atype="GSC" type="Res" conceptID="Res18" novelty="None" advantage="None"/></s>
          <s sid="117">We also used a multivariate logistic regression model with all food groups to generate a "dietary propensity factor," which could be interpreted as a score integrating the risk of colorectal cancer associated with diet.<CoreSc1 atype="GSC" type="Met" conceptID="Met42" novelty="None" advantage="None"/></s>
          <s sid="118">Adjusting OCs for this dietary propensity factor did not modify the risk estimates, showing again that diet was not a confounding factor.<CoreSc1 atype="GSC" type="Res" conceptID="Res19" novelty="None" advantage="None"/></s>
          <s sid="119">Hence, after careful consideration, adjustment of the analyses for food groups was found to be unnecessary because foods were not clearly related to serum OC levels and, more important, did not modify the risk estimates.<CoreSc1 atype="GSC" type="Con" conceptID="Con3" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="120">An exploratory analysis of interactions between mono-<italic>ortho</italic> PCBs and several variables was carried out.<CoreSc1 atype="GSC" type="Met" conceptID="Met43" novelty="None" advantage="None"/></s>
          <s sid="121">The magnitude of the risk of colorectal cancer observed for these OCs was not modified by sex, age, BMI, smoking, NSAIDs use, or parity in women.<CoreSc1 atype="GSC" type="Res" conceptID="Res20" novelty="None" advantage="None"/></s>
          <s sid="122">Analysis of interactions with other hormonal variables in women could not be performed because only six women were exposed to oral contraceptives and only two to postmenopausal hormone replacement treatments.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot2" novelty="None" advantage="None"/></s>
          <s sid="123">Because alcohol was an important risk factor in this study and alcohol intake produces metabolic induction similar to that produced by some OCs (<xref ref-type="bibr" rid="r30">Mochizuki and Yoshida 1989</xref>), interactions between OCs and alcohol were explored in detail, but none was significant.<CoreSc1 atype="GSC" type="Res" conceptID="Res21" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="124"><bold><italic>OC levels and mutations at the K-</italic>ras <italic>and</italic> p53 <italic>genes.</italic></bold> K-<italic>ras</italic> was mutated in 50 (38%) cases.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs13" novelty="None" advantage="None"/></s>
          <s sid="125">Most frequent mutations were GAT (<italic>n</italic> = 16) and GTT (<italic>n</italic> = 15) in codon 12.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs14" novelty="None" advantage="None"/></s>
          <s sid="126">In 6 cases, codon 13 was mutated to GAC.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs15" novelty="None" advantage="None"/></s>
          <s sid="127">Other, less frequent mutations in codon 12 were TGT (<italic>n</italic> = 5), AGT (<italic>n</italic> = 4), GCT (<italic>n</italic> = 3), and CGT (<italic>n</italic> = 1).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs16" novelty="None" advantage="None"/></s>
          <s sid="128">Twenty-six mutations were transitions (G:C &#8594; A:T), and 24 were transversions (G: C &#8594; T:A).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs17" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="129">Tumor suppressor gene <italic>p53</italic> was mutated in 59 (60%) of the tumors analyzed (data not available for 34 cases).<CoreSc1 atype="GSC" type="Res" conceptID="Res22" novelty="None" advantage="None"/></s>
          <s sid="130">Twenty-four mutations were located in hotspots: codon 175 (<italic>n</italic> = 4), codon 245 (<italic>n</italic> = 3), codon 248 (<italic>n</italic> = 3), codon 273 (<italic>n</italic> = 6), and codon 282 (<italic>n</italic> = 8).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs18" novelty="None" advantage="None"/></s>
          <s sid="131">Four cases harbored mutations at codon 158, the remaining being detected at 24 different codons with frequencies &#8804; 2.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs19" novelty="None" advantage="None"/></s>
          <s sid="132">Forty mutations were transitions, and 15 were transversions; in the remaining four cases, deletions were detected.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs20" novelty="None" advantage="None"/></s>
          <s sid="133">The most frequent base changes were C&#8594;T and G&#8594;A, each in 17 cases, mainly at hotspot sites.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs21" novelty="None" advantage="None"/></s>
          <s sid="134">G&#8594;T changes were observed in eight cases and distributed with a nonclustered profile.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs22" novelty="None" advantage="None"/></s>
          <s sid="135">The immunohistochemical analyses showed that 76% of the cases overexpressed the p53 protein.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs23" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="136"><xref ref-type="table" rid="t5">Table 5</xref> shows the analysis of selected OCs where the cases have been stratified by mutations in K-<italic>ras</italic> and <italic>p53</italic>.<CoreSc1 atype="GSC" type="Res" conceptID="Res23" novelty="None" advantage="None"/></s>
          <s sid="137">This analysis is based on polytomous logistic regression, and each group of cases is compared with controls in a unified model.<CoreSc1 atype="GSC" type="Met" conceptID="Met44" novelty="None" advantage="None"/></s>
          <s sid="138">Exposure to mono-<italic>ortho</italic> PCBs 28 and 118 increased risk in similar magnitude for both mutated and wild-type K-<italic>ras</italic>.<CoreSc1 atype="GSC" type="Res" conceptID="Res24" novelty="None" advantage="None"/></s>
          <s sid="139">PCB-118, but not PCB-28, showed higher risk for <italic>p53</italic>-mutated tumors, although the interaction was not significant.<CoreSc1 atype="GSC" type="Res" conceptID="Res25" novelty="None" advantage="None"/></s>
          <s sid="140">This stratification of cases by genetic alterations also showed some significant interactions with other OCs.<CoreSc1 atype="GSC" type="Res" conceptID="Res26" novelty="None" advantage="None"/></s>
          <s sid="141">High levels of <italic>p</italic>,<italic>p</italic>&#180;-DDE were associated with increased risk of cancer with wild-type K-<italic>ras</italic>.<CoreSc1 atype="GSC" type="Res" conceptID="Res27" novelty="None" advantage="None"/></s>
          <s sid="142">Also, <italic>p</italic>,<italic>p</italic>&#180;-DDE and &#593;-HCH had significant effects on <italic>p53</italic>-mutated tumors.<CoreSc1 atype="GSC" type="Res" conceptID="Res28" novelty="None" advantage="None"/></s>
          <s sid="143">A similar pattern was evident when tumors were stratified according to p53 overexpression: <italic>p</italic>,<italic>p</italic>&#180;-DDE and PCB-118 increased the risk only for tumors overexpressing p53 protein.<CoreSc1 atype="GSC" type="Res" conceptID="Res29" novelty="None" advantage="None"/></s>
          <s sid="144">Tumors with microsatellite instability were rare (<italic>n</italic> = 11, 8%), and these patients had similar OC levels to other cases.<CoreSc1 atype="GSC" type="Res" conceptID="Res30" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="145">Overall, 81% of the tumors harbored K-<italic>ras</italic> and/or <italic>p53</italic> gene mutations, and a combined analysis was performed.<CoreSc1 atype="GSC" type="Res" conceptID="Res31" novelty="None" advantage="None"/></s>
          <s sid="146">Exposure to high levels of the mono-<italic>ortho</italic> PCB-118 was associated with more mutations (OR = 2.89; 95% CI, 0.66-12.7), with transversions three &#215; more likely than transitions (<xref ref-type="table" rid="t6">Table 6</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res32" novelty="None" advantage="None"/></s>
          <s sid="147">Other OCs analyzed in this way were not related to the type of mutation.<CoreSc1 atype="GSC" type="Res" conceptID="Res33" novelty="None" advantage="None"/></s>
        </p>
      </sec>
      <sec sec-type="discussion">
        <title>Discussion</title>
        <p>
          <s sid="148">OCs have previously been associated with increased risk of colorectal cancers in studies of occupationally exposed individuals (<xref ref-type="bibr" rid="r1">Acquavella et al. 1996</xref>; <xref ref-type="bibr" rid="r41">Soliman et al. 1997</xref>; <xref ref-type="bibr" rid="r45">Wilkinson et al. 1997</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac27" novelty="None" advantage="None"/></s>
          <s sid="149">Other studies have failed to show this association (<xref ref-type="bibr" rid="r19">Hardell 1981</xref>; <xref ref-type="bibr" rid="r20">Hoar et al. 1985</xref>; <xref ref-type="bibr" rid="r39">Settimi et al. 2001</xref>) or even have shown inverse associations with colon cancer (<xref ref-type="bibr" rid="r12">Cantor and Silberman 1999</xref>; <xref ref-type="bibr" rid="r44">Wang et al. 2002</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac28" novelty="None" advantage="None"/></s>
          <s sid="150">These mixed results are not surprising because most occupational studies lack individual exposure indicators and are prone to confounding.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj4" novelty="None" advantage="None"/></s>
          <s sid="151">To overcome these limitations, we studied a population not occupationally exposed using serum OC levels as exposure markers.<CoreSc1 atype="GSC" type="Met" conceptID="Met45" novelty="None" advantage="None"/></s>
          <s sid="152">We found an elevated risk of colorectal cancer associated with high levels of mono-<italic>ortho</italic> PCBs 28 and 118.<CoreSc1 atype="GSC" type="Res" conceptID="Res34" novelty="None" advantage="None"/></s>
          <s sid="153">Other abundant OCs such as <italic>p</italic>,<italic>p</italic>&#180;-DDE and &#593;-HCH also showed an increased risk of relevant magnitude; although the associations for these OCs were not significant for the entire population of cases, they were significant for the subset of tumors harboring mutations of the <italic>p53</italic> gene.<CoreSc1 atype="GSC" type="Res" conceptID="Res35" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="154">We have taken serum concentrations of OCs as indicative of the body burden.<CoreSc1 atype="GSC" type="Met" conceptID="Met46" novelty="None" advantage="None"/></s>
          <s sid="155">Serum concentrations are strongly correlated with those in adipose tissue and feces and reflect the historical legacy of uptake and depuration, and as such, they may be taken as markers for long-term, low-level exposure (<xref ref-type="bibr" rid="r2">Alcock et al. 2000</xref>; <xref ref-type="bibr" rid="r25">Juan et al. 2002</xref>; <xref ref-type="bibr" rid="r31">Moser and McLachlan 2001</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met47" novelty="None" advantage="None"/></s>
          <s sid="156">Many studies that also used plasma OC concentrations as exposure markers have reported mixed results for breast cancer (<xref ref-type="bibr" rid="r11">Calle et al. 2002</xref>) and non-Hodgkin lymphoma (<xref ref-type="bibr" rid="r13">Cantor et al. 2003</xref>; <xref ref-type="bibr" rid="r16">De Roos et al. 2003</xref>; <xref ref-type="bibr" rid="r36">Rothman et al. 1997</xref>) but increased risk of pancreatic cancer (<xref ref-type="bibr" rid="r21">Hoppin et al. 2000</xref>; <xref ref-type="bibr" rid="r33">Porta et al. 1999</xref>; <xref ref-type="bibr" rid="r40">Slebos et al. 2000</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac29" novelty="None" advantage="None"/></s>
          <s sid="157">Altogether, these results suggest that a role for OCs in the etiology of several tumors is likely.<CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/></s>
          <s sid="158">Nevertheless, the mechanisms underlying carcinogenicity will differ among both OCs and target organs because chemical properties and toxicity mechanisms of these compounds are diverse.<CoreSc1 atype="GSC" type="Con" conceptID="Con5" novelty="None" advantage="None"/></s>
          <s sid="159">In addition, target organs differing in lipid content might determine distinct degree of local exposure.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp2" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="160">In our population, high body burdens of mono-<italic>ortho</italic> PCBs 28 and 118 were associated with an elevated risk of colorectal cancer.<CoreSc1 atype="GSC" type="Res" conceptID="Res36" novelty="None" advantage="None"/></s>
          <s sid="161">These OCs are among the most toxic of the PCBs, together with non-<italic>ortho</italic> PCBs.<CoreSc1 atype="GSC" type="Res" conceptID="Res37" novelty="None" advantage="None"/></s>
          <s sid="162">The relatively flat (or "planar") orientation of their biphenyl rings allows them to bind to the aryl hydrocarbon (Ah) receptor in a similar way to polychlorinated dibenzodioxins and dibenzofurans and may be responsible for our finding (<xref ref-type="bibr" rid="r37">Safe 1990</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac30" novelty="None" advantage="None"/></s>
          <s sid="163">This binding induces phase I and phase II metabolic enzymes; mono-<italic>ortho</italic> PCBs may therefore induce CYP1A and CYP2B enzymes that, in the absence of substrate, can produce reactive oxygen species.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac31" novelty="None" advantage="None"/></s>
          <s sid="164">Although PCB-118 has a toxic equivalency factor (TEF) of 0.0001, based on its toxicity relative to 2,3,7,8-tetrachlorinated dibenzo-<italic>p</italic>-dioxin (<xref ref-type="bibr" rid="r43">Van den Berg et al. 1998</xref>), PCB-28 has not been assigned a TEF under this scheme and may not, therefore, bind strongly to the Ah receptor and/or significantly induce CYP enzymes.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac32" novelty="None" advantage="None"/></s>
          <s sid="165">Nevertheless, higher serum levels of PCB-28 were associated with increased risk of colon cancer in this study.<CoreSc1 atype="GSC" type="Res" conceptID="Res38" novelty="None" advantage="None"/></s>
          <s sid="166">Some studies on breast cancer have also reported increased risk being limited to mono-<italic>ortho</italic> PCBs (<xref ref-type="bibr" rid="r4">Aronson et al. 2000</xref>; <xref ref-type="bibr" rid="r15">Demers et al. 2002</xref>; <xref ref-type="bibr" rid="r28">Lucena et al. 2001</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac33" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="167">PCBs themselves are hydroxylated by cytochrome P450 enzymes, and their metabolites have been shown to induce DNA adducts <italic>invitro</italic> (<xref ref-type="bibr" rid="r29">McLean et al. 1996</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac34" novelty="None" advantage="None"/></s>
          <s sid="168">We have not observed a clear differential risk for PCB-28 or PCB-118 in relation to K <italic>ras</italic> or <italic>p53</italic> mutations.<CoreSc1 atype="GSC" type="Res" conceptID="Res39" novelty="None" advantage="None"/></s>
          <s sid="169">However, when mutations in both genes were classified according to their molecular nature, an association between transversions (less likely to occur spontaneously) and exposure to mono-<italic>ortho</italic> PCBs was observed.<CoreSc1 atype="GSC" type="Res" conceptID="Res40" novelty="None" advantage="None"/></s>
          <s sid="170">This could be interpreted as indirect evidence for a molecular fingerprint associated with exposure to these pollutants.<CoreSc1 atype="GSC" type="Con" conceptID="Con6" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="171">The role of other OCs in colorectal cancer risk may be more complex.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot3" novelty="None" advantage="None"/></s>
          <s sid="172">Compounds such as <italic>p</italic>,<italic>p</italic>&#180;-DDE and &#593;-HCH that had an overall moderate association with colorectal cancer showed a significant increase in risk for tumors with mutation of the <italic>p53</italic> gene.<CoreSc1 atype="GSC" type="Res" conceptID="Res41" novelty="None" advantage="None"/></s>
          <s sid="173">A similar result was reported in a Danish study, where higher risk of breast cancer with mutated <italic>p53</italic> was observed among women exposed to high levels of dieldrin and PCBs (<xref ref-type="bibr" rid="r22">Hoyer et al. 2002</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac35" novelty="None" advantage="None"/></s>
          <s sid="174">In our population, <italic>p</italic>,<italic>p</italic>&#180;-DDE also increased risk for tumors with wild-type K-<italic>ras</italic> but not when this oncogene was mutated.<CoreSc1 atype="GSC" type="Res" conceptID="Res42" novelty="None" advantage="None"/></s>
          <s sid="175">Previous studies in pancreatic cancer have provided mixed results regarding OC exposure and K-<italic>ras</italic> mutation status associated with DDE levels (<xref ref-type="bibr" rid="r33">Porta et al. 1999</xref>; <xref ref-type="bibr" rid="r40">Slebos et al. 2000</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac36" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="176">Several factors suggest that these findings may be causal: the strength and trend of the associations observed; the restriction of the findings to mono-<italic>ortho</italic> PCBs that have a relatively planar, dioxin-like structure; the existence of similar findings in tumors from other organs; the plausibility of carcinogenic mechanisms; and the association with specific mutation types.<CoreSc1 atype="GSC" type="Con" conceptID="Con7" novelty="None" advantage="None"/></s>
          <s sid="177">We are aware, however, that this study also has several limitations.<CoreSc1 atype="GSC" type="Met" conceptID="Met48" novelty="None" advantage="None"/></s>
          <s sid="178">Owing to the limitations of our analytical method, we did not study non-<italic>ortho</italic> PCBs that have a greater affinity for the Ah receptor than do mono-<italic>ortho</italic> PCBs as a result of their "coplanar" molecular structure, which may have strengthened our hypothesis.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot4" novelty="None" advantage="None"/></s>
          <s sid="179">The retrospective assessment of exposure in the case-control design is not ideal, and the use of hospital controls may introduce information and selection bias.<CoreSc1 atype="GSC" type="Met" conceptID="Met49" novelty="None" advantage="None"/></s>
          <s sid="180">We minimized these biases by careful design, the use of validated questionnaires administered by trained interviewers, and robust analytical methods.<CoreSc1 atype="GSC" type="Met" conceptID="Met50" novelty="None" advantage="None"/></s>
          <s sid="181">However, potential sources of nondifferential bias would tend to decrease the magnitude of any positive relationship; in particular, if OC exposure increased the risk of hospital admission, this would bias the associations toward the null hypothesis.<CoreSc1 atype="GSC" type="Met" conceptID="Met51" novelty="None" advantage="None"/></s>
          <s sid="182">Furthermore, potential confounding factors were explored in detail and rejected.<CoreSc1 atype="GSC" type="Met" conceptID="Met52" novelty="None" advantage="None"/></s>
          <s sid="183">Special effort was devoted to explore whether the weight loss observed among cases could explain the results, because OCs accumulate in lipids, and changes in BMI due to metabolism of adipose tissue in cancer patients could result in higher serum levels of OCs.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp3" novelty="None" advantage="None"/></s>
          <s sid="184">However, three observations combine to negate this possibility: <italic>a</italic>) adjusting for BMI had only a minor effect on risk estimates; <italic>b</italic>) although more advanced cases exhibited severe weight loss, there was no association between OC levels and tumor stage; and <italic>c</italic>) if lipid mobilization was the reason for observing higher OC levels among cases, this would be true for all OCs but especially the more lipophilic compounds, whereas we observed increased risk only for selected OCs, and these were less lipophilic than <italic>p</italic>,<italic>p</italic>&#180;-DDT and PCB-138, PCB-153, and PCB-180, for which no increased risk was observed.<CoreSc1 atype="GSC" type="Res" conceptID="Res43" novelty="None" advantage="None"/></s>
          <s sid="185">Nevertheless, we cannot exclude chance as an explanation of some of the results because this study was conceived as exploratory or hypothesis generating and we performed many statistical comparisons.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot5" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="186">In conclusion, these results suggest that exposure to mono-<italic>ortho</italic> PCBs is associated with an increased risk of colorectal cancer.<CoreSc1 atype="GSC" type="Con" conceptID="Con8" novelty="None" advantage="None"/></s>
          <s sid="187">The trend and magnitude of the association and the specific toxic action of these PCBs, linked with transversion-type mutations, suggest that this finding may be causal.<CoreSc1 atype="GSC" type="Con" conceptID="Con9" novelty="None" advantage="None"/></s>
          <s sid="188">This hypothesis merits confirmation in other studies that would benefit from including other mono-<italic>ortho</italic> PCBs, as well as non-<italic>ortho</italic> PCBs and perhaps dioxins/furans.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot6" novelty="None" advantage="None"/></s>
        </p>
      </sec>
    </body>
    <back>
      <ack>
        <p>We thank E. Marco, R. Mas, R. Chaler, and D. Fanjul for their assistance with organochlorine analysis.</p>
      </ack>
      <fn-group>
        <fn fn-type="financial-disclosure">
          <p>The study was supported by grants from the Fundaci&#243; La Marat&#243; de TV3 (48/95), the Spanish Fondo de Investigaciones Sanitarias (FIS 96/0797, FIS 00/0027, FIS 01/1264, FIS 03/0114, ISCIII, Red de Centros RCESP C03/09, and Red de Centros de Cancer C03/10) and Comisi&#243;n Interministerial de Ciencia y Tecnolog&#237;a (SAF 00/81), and a European Union Marie Curie Fellowship for M.H. (HPMF-CT-2000-00888).</p>
        </fn>
        <fn fn-type="conflict">
          <p>The authors declare they have no competing financial interests.</p>
        </fn>
      </fn-group>
      <ref-list>
        <title>References</title>
        <ref id="r1">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Acquavella</surname>
                <given-names>JF</given-names>
              </name>
              <name name-style="western">
                <surname>Riordan</surname>
                <given-names>SG</given-names>
              </name>
              <name name-style="western">
                <surname>Anne</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Lynch</surname>
                <given-names>CF</given-names>
              </name>
              <name name-style="western">
                <surname>Collins</surname>
                <given-names>JJ</given-names>
              </name>
              <name name-style="western">
                <surname>Ireland</surname>
                <given-names>BK</given-names>
              </name>
              <etal/>
            </person-group>
            <year>1996</year>
            <article-title>Evaluation of mortality and cancer incidence among alachlor manufacturing workers.</article-title>
            <source>Environ Health Perspect</source>
            <volume>104</volume>
            <fpage>728</fpage>
            <lpage>733</lpage>
          </citation>
        </ref>
        <ref id="r2">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Alcock</surname>
                <given-names>RE</given-names>
              </name>
              <name name-style="western">
                <surname>Sweetman</surname>
                <given-names>AJ</given-names>
              </name>
              <name name-style="western">
                <surname>Juan</surname>
                <given-names>CY</given-names>
              </name>
              <name name-style="western">
                <surname>Jones</surname>
                <given-names>KC</given-names>
              </name>
            </person-group>
            <year>2000</year>
            <article-title>A generic model of human lifetime exposure to persistent organic contaminants: development and application to PCB-101.</article-title>
            <source>Environ Pollut</source>
            <volume>110</volume>
            <fpage>253</fpage>
            <lpage>265</lpage>
          </citation>
        </ref>
        <ref id="r3">
          <citation citation-type="web" xlink:type="simple">
            <comment>AMAP. 2004. Arctic Monitoring and Assessment Programme. Oslo:AMAP Secretariat. Available: <ext-link ext-link-type="uri" xlink:href="http://www.amap.no" xlink:type="simple">http://www.amap.no</ext-link> [accessed 1July 2004].</comment>
          </citation>
        </ref>
        <ref id="r4">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Aronson</surname>
                <given-names>KJ</given-names>
              </name>
              <name name-style="western">
                <surname>Miller</surname>
                <given-names>AB</given-names>
              </name>
              <name name-style="western">
                <surname>Woolcott</surname>
                <given-names>CG</given-names>
              </name>
              <name name-style="western">
                <surname>Sterns</surname>
                <given-names>EE</given-names>
              </name>
              <name name-style="western">
                <surname>McCready</surname>
                <given-names>DR</given-names>
              </name>
              <name name-style="western">
                <surname>Lickley</surname>
                <given-names>LA</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2000</year>
            <article-title>Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk.</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>55</fpage>
            <lpage>63</lpage>
          </citation>
        </ref>
        <ref id="r5">
          <citation citation-type="web" xlink:type="simple">
            <comment>ATSDR. 2000. Toxicological Profile for Polychlorinated Biphenyls (PCBs). Atlanta, GA:Agency for Toxic Substances and Disease Registry. Available: <ext-link ext-link-type="uri" xlink:href="http://www.atsdr.cdc.gov/toxprofiles/tp17.html" xlink:type="simple">http://www.atsdr.cdc.gov/toxprofiles/tp17.html</ext-link> [accessed 1July 2004].</comment>
          </citation>
        </ref>
        <ref id="r6">
          <citation citation-type="web" xlink:type="simple">
            <comment>ATSDR. 2002. Toxicological Profile for DDT, DDE, DDD. Atlanta, GA:Agency for Toxic Substances and Disease Registry. Available: <ext-link ext-link-type="uri" xlink:href="http://www.atsdr.cdc.gov/toxprofiles/tp35.html" xlink:type="simple">http://www.atsdr.cdc.gov/toxprofiles/tp35.html</ext-link> [accessed 1July 2004].</comment>
          </citation>
        </ref>
        <ref id="r7">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Bertazzi</surname>
                <given-names>PA</given-names>
              </name>
              <name name-style="western">
                <surname>Riboldi</surname>
                <given-names>L</given-names>
              </name>
              <name name-style="western">
                <surname>Pesatori</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Radice</surname>
                <given-names>L</given-names>
              </name>
              <name name-style="western">
                <surname>Zocchetti</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <year>1987</year>
            <article-title>Cancer mortality of capacitor manufacturing workers.</article-title>
            <source>Am J Ind Med</source>
            <volume>11</volume>
            <issue>2</issue>
            <fpage>165</fpage>
            <lpage>176</lpage>
          </citation>
        </ref>
        <ref id="r8">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Borlakoglu</surname>
                <given-names>JT</given-names>
              </name>
              <name name-style="western">
                <surname>Walker</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <year>1989</year>
            <article-title>Comparative aspects of congener specific PCB metabolism.</article-title>
            <source>Eur J Drug Metab Pharmacokinet</source>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>127</fpage>
            <lpage>131</lpage>
          </citation>
        </ref>
        <ref id="r9">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Brown</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <year>1987</year>
            <article-title>Mortality of workers exposed to polychlorinated biphenyls--an update.</article-title>
            <source>Arch Environ Health</source>
            <volume>42</volume>
            <issue>6</issue>
            <fpage>333</fpage>
            <lpage>339</lpage>
          </citation>
        </ref>
        <ref id="r10">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Caldwell</surname>
                <given-names>GG</given-names>
              </name>
              <name name-style="western">
                <surname>Cannon</surname>
                <given-names>SB</given-names>
              </name>
              <name name-style="western">
                <surname>Pratt</surname>
                <given-names>CB</given-names>
              </name>
              <name name-style="western">
                <surname>Arthur</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <year>1981</year>
            <article-title>Serum pesticide levels in patients with childhood colorectal carcinoma.</article-title>
            <source>Cancer</source>
            <volume>48</volume>
            <issue>3</issue>
            <fpage>774</fpage>
            <lpage>778</lpage>
          </citation>
        </ref>
        <ref id="r11">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Calle</surname>
                <given-names>EE</given-names>
              </name>
              <name name-style="western">
                <surname>Frumkin</surname>
                <given-names>H</given-names>
              </name>
              <name name-style="western">
                <surname>Henley</surname>
                <given-names>SJ</given-names>
              </name>
              <name name-style="western">
                <surname>Savitz</surname>
                <given-names>DA</given-names>
              </name>
              <name name-style="western">
                <surname>Thun</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <year>2002</year>
            <article-title>Organochlorines and breast cancer risk.</article-title>
            <source>CA Cancer J Clin</source>
            <volume>52</volume>
            <issue>5</issue>
            <fpage>301</fpage>
            <lpage>309</lpage>
          </citation>
        </ref>
        <ref id="r12">
          <citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Cantor</surname><given-names>KP</given-names></name><name name-style="western"><surname>Silberman</surname><given-names>W</given-names></name></person-group><year>1999</year><article-title>Mortality among aerial pesticide applicators and flight instructors: follow-up from 1965-1988.</article-title><source>Am J Ind Med</source><volume>36</volume><issue>2</issue>): <fpage>239</fpage><lpage>247</lpage></citation>
        </ref>
        <ref id="r13">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Cantor</surname>
                <given-names>KP</given-names>
              </name>
              <name name-style="western">
                <surname>Strickland</surname>
                <given-names>PT</given-names>
              </name>
              <name name-style="western">
                <surname>Brock</surname>
                <given-names>JW</given-names>
              </name>
              <name name-style="western">
                <surname>Bush</surname>
                <given-names>D</given-names>
              </name>
              <name name-style="western">
                <surname>Helzlsouer</surname>
                <given-names>K</given-names>
              </name>
              <name name-style="western">
                <surname>Needham</surname>
                <given-names>LL</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2003</year>
            <article-title>Risk of non-Hodgkin's lymphoma and prediagnostic serum organochlorines: beta-hexachlorocyclohexane, chlordane/heptachlor-related compounds, dieldrin, and hexachlorobenzene.</article-title>
            <source>Environ Health Perspect</source>
            <volume>111</volume>
            <fpage>179</fpage>
            <lpage>183</lpage>
          </citation>
        </ref>
        <ref id="r14">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Davis</surname>
                <given-names>DL</given-names>
              </name>
              <name name-style="western">
                <surname>Bradlow</surname>
                <given-names>HL</given-names>
              </name>
              <name name-style="western">
                <surname>Wolff</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Woodruff</surname>
                <given-names>T</given-names>
              </name>
              <name name-style="western">
                <surname>Hoel</surname>
                <given-names>DG</given-names>
              </name>
              <name name-style="western">
                <surname>Anton-Culver</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <year>1993</year>
            <article-title>Medical hypothesis: xenoestrogens as preventable causes of breast cancer.</article-title>
            <source>Environ Health Perspect</source>
            <volume>101</volume>
            <fpage>372</fpage>
            <lpage>377</lpage>
          </citation>
        </ref>
        <ref id="r15">
          <citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Demers</surname><given-names>A</given-names></name><name name-style="western"><surname>Ayotte</surname><given-names>P</given-names></name><name name-style="western"><surname>Brisson</surname><given-names>J</given-names></name><name name-style="western"><surname>Dodin</surname><given-names>S</given-names></name><name name-style="western"><surname>Robert</surname><given-names>J</given-names></name><name name-style="western"><surname>Dewailly</surname><given-names>E.</given-names></name></person-group><year>2002</year><article-title>Plasma concentrations of polychlorinated biphenyls and the risk of breast cancer: a congener-specific analysis.</article-title><source>Am J Epidemiol</source><volume>155</volume><issue>7</issue>): <fpage>629</fpage><lpage>635</lpage></citation>
        </ref>
        <ref id="r16">
          <citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>De Roos</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Zahm</surname><given-names>SH</given-names></name><name name-style="western"><surname>Cantor</surname><given-names>KP</given-names></name><name name-style="western"><surname>Weisenburger</surname><given-names>DD</given-names></name><name name-style="western"><surname>Holmes</surname><given-names>FF</given-names></name><name name-style="western"><surname>Burmeister</surname><given-names>LF</given-names></name><etal/></person-group><year>2003</year><article-title>Integrative assessment of multiple pesticides as risk factors for non-Hodgkin's lymphoma among men.</article-title><source>Occup Environ Med</source><volume>60</volume><issue>9</issue><fpage>E11</fpage>. Available: <ext-link ext-link-type="uri" xlink:href="http://oem.bmjjournals.com/cgi/content/full/60/9/e11" xlink:type="simple">http://oem.bmjjournals.com/cgi/content/full/60/9/e11</ext-link><comment>[accessed 26 August 2004]</comment></citation>
        </ref>
        <ref id="r17">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <collab xlink:type="simple">EPIC Group of Spain</collab>
            </person-group>
            <year>1997</year>
            <article-title>Relative validity and reproducibility of a diet history questionnaire in Spain. I. Foods.</article-title>
            <source>Int J Epidemiol</source>
            <volume>26</volume>
            <supplement>suppl 1</supplement>
            <fpage>S91</fpage>
            <lpage>S99</lpage>
          </citation>
        </ref>
        <ref id="r18">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Gonzalez-Garcia</surname>
                <given-names>I</given-names>
              </name>
              <name name-style="western">
                <surname>Moreno</surname>
                <given-names>V</given-names>
              </name>
              <name name-style="western">
                <surname>Navarro</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Marti-Rague</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Marcuello</surname>
                <given-names>E</given-names>
              </name>
              <name name-style="western">
                <surname>Benasco</surname>
                <given-names>C</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2000</year>
            <article-title>Standardized approach for microsatellite instability detection in colorectal carcinomas.</article-title>
            <source>J Natl Cancer Inst</source>
            <volume>92</volume>
            <issue>7</issue>
            <fpage>544</fpage>
            <lpage>549</lpage>
          </citation>
        </ref>
        <ref id="r19">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Hardell</surname>
                <given-names>L.</given-names>
              </name>
            </person-group>
            <year>1981</year>
            <article-title>Relation of soft-tissue sarcoma, malignant lymphoma and colon cancer to phenoxy acids, chlorophenols and other agents.</article-title>
            <source>Scand J Work Environ Health</source>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>119</fpage>
            <lpage>130</lpage>
          </citation>
        </ref>
        <ref id="r20">
          <citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Hoar</surname><given-names>SK</given-names></name><name name-style="western"><surname>Blair</surname><given-names>A</given-names></name><name name-style="western"><surname>Holmes</surname><given-names>FF</given-names></name><name name-style="western"><surname>Boysen</surname><given-names>C</given-names></name><name name-style="western"><surname>Robel</surname><given-names>RJ</given-names></name></person-group><year>1985</year><article-title>Herbicides and colon cancer.</article-title><source>Lancet</source><volume>1</volume><issue>8440</issue>): <fpage>1277</fpage><lpage>1278</lpage></citation>
        </ref>
        <ref id="r21">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Hoppin</surname>
                <given-names>JA</given-names>
              </name>
              <name name-style="western">
                <surname>Tolbert</surname>
                <given-names>PE</given-names>
              </name>
              <name name-style="western">
                <surname>Holly</surname>
                <given-names>EA</given-names>
              </name>
              <name name-style="western">
                <surname>Brock</surname>
                <given-names>JW</given-names>
              </name>
              <name name-style="western">
                <surname>Korrick</surname>
                <given-names>SA</given-names>
              </name>
              <name name-style="western">
                <surname>Altshul</surname>
                <given-names>LM</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2000</year>
            <article-title>Pancreatic cancer and serum organochlorine levels.</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>199</fpage>
            <lpage>205</lpage>
          </citation>
        </ref>
        <ref id="r22">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Hoyer</surname>
                <given-names>AP</given-names>
              </name>
              <name name-style="western">
                <surname>Gerdes</surname>
                <given-names>AM</given-names>
              </name>
              <name name-style="western">
                <surname>Jorgensen</surname>
                <given-names>T</given-names>
              </name>
              <name name-style="western">
                <surname>Rank</surname>
                <given-names>F</given-names>
              </name>
              <name name-style="western">
                <surname>Hartvig</surname>
                <given-names>HB</given-names>
              </name>
            </person-group>
            <year>2002</year>
            <article-title>Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case-controls study.</article-title>
            <source>Breast Cancer Res Treat</source>
            <volume>71</volume>
            <issue>1</issue>
            <fpage>59</fpage>
            <lpage>65</lpage>
          </citation>
        </ref>
        <ref id="r23">
          <citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><collab xlink:type="simple">IARC</collab></person-group><year>1987</year><article-title>Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42.</article-title><source>IARC Monogr Eval Carcinog Risk Hum</source><supplement>Suppl 7</supplement>:<fpage>1</fpage><lpage>440</lpage></citation>
        </ref>
        <ref id="r24">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <collab xlink:type="simple">IARC</collab>
            </person-group>
            <year>1991</year>
            <article-title>Occupational exposures in insecticide application, and some pesticides.</article-title>
            <source>IARC Monogr Eval Carcinog Risk Hum</source>
            <volume>53</volume>
            <fpage>179</fpage>
            <lpage>250</lpage>
          </citation>
        </ref>
        <ref id="r25">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Juan</surname>
                <given-names>CY</given-names>
              </name>
              <name name-style="western">
                <surname>Thomas</surname>
                <given-names>GO</given-names>
              </name>
              <name name-style="western">
                <surname>Sweetman</surname>
                <given-names>AJ</given-names>
              </name>
              <name name-style="western">
                <surname>Jones</surname>
                <given-names>KC</given-names>
              </name>
            </person-group>
            <year>2002</year>
            <article-title>An input-output balance study for PCBs in humans.</article-title>
            <source>Environ Int</source>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>203</fpage>
            <lpage>214</lpage>
          </citation>
        </ref>
        <ref id="r26">
          <citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Landi</surname><given-names>S</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>V</given-names></name><name name-style="western"><surname>Gioia-Patricola</surname><given-names>L</given-names></name><name name-style="western"><surname>Guino</surname><given-names>E</given-names></name><name name-style="western"><surname>Navarro</surname><given-names>M</given-names></name><name name-style="western"><surname>de Oca</surname><given-names>J</given-names></name></person-group>, etal. <year>2003</year><article-title>Association of common polymorphisms in inflammatory genes interleukin (<italic>IL</italic>)6, <italic>IL8</italic>, tumor necrosis factor &#593;, <italic>NFKB1</italic>, and peroxisome proliferator-activated receptor &#611; with colorectal cancer.</article-title><source>Cancer Res</source><volume>63</volume><issue>13</issue><fpage>3560</fpage><lpage>3566</lpage></citation>
        </ref>
        <ref id="r27">
          <citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Leet</surname><given-names>T</given-names></name><name name-style="western"><surname>Acquavella</surname><given-names>J</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>C</given-names></name><name name-style="western"><surname>Anne</surname><given-names>M</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>NS</given-names></name><name name-style="western"><surname>Vaughan</surname><given-names>T</given-names></name></person-group>, etal. <year>1996</year><article-title>Cancer incidence among alachlor manufacturing workers.</article-title><source>Am J Ind Med</source><volume>30</volume><issue>3</issue><fpage>300</fpage><lpage>306</lpage></citation>
        </ref>
        <ref id="r28">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Lucena</surname>
                <given-names>RA</given-names>
              </name>
              <name name-style="western">
                <surname>Allam</surname>
                <given-names>MF</given-names>
              </name>
              <name name-style="western">
                <surname>Costabeber</surname>
                <given-names>IH</given-names>
              </name>
              <name name-style="western">
                <surname>Villarejo</surname>
                <given-names>ML</given-names>
              </name>
              <name name-style="western">
                <surname>Navajas</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <year>2001</year>
            <article-title>Breast cancer risk factors: PCB congeners.</article-title>
            <source>Eur J Cancer Prev</source>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>117</fpage>
            <lpage>119</lpage>
          </citation>
        </ref>
        <ref id="r29">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>McLean</surname>
                <given-names>MR</given-names>
              </name>
              <name name-style="western">
                <surname>Robertson</surname>
                <given-names>LW</given-names>
              </name>
              <name name-style="western">
                <surname>Gupta</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <year>1996</year>
            <article-title>Detection of PCB adducts by the 32P-postlabeling technique.</article-title>
            <source>Chem Res Toxicol</source>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>165</fpage>
            <lpage>171</lpage>
          </citation>
        </ref>
        <ref id="r30">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Mochizuki</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Yoshida</surname>
                <given-names>A.</given-names>
              </name>
            </person-group>
            <year>1989</year>
            <article-title>Effects of dietary ethanol on ascorbic acid and lipid metabolism, and liver drug-metabolizing enzymes in rats.</article-title>
            <source>J Nutr Sci Vitaminol (Tokyo)</source>
            <volume>35</volume>
            <issue>5</issue>
            <fpage>431</fpage>
            <lpage>440</lpage>
          </citation>
        </ref>
        <ref id="r31">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Moser</surname>
                <given-names>GA</given-names>
              </name>
              <name name-style="western">
                <surname>McLachlan</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <year>2001</year>
            <article-title>The influence of dietary concentration on the absorption and excretion of persistent lipophilic organic pollutants in the human intestinal tract.</article-title>
            <source>Chemosphere</source>
            <volume>45</volume>
            <issue>2</issue>
            <fpage>201</fpage>
            <lpage>211</lpage>
          </citation>
        </ref>
        <ref id="r32">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Phillips</surname>
                <given-names>DL</given-names>
              </name>
              <name name-style="western">
                <surname>Pirkle</surname>
                <given-names>JL</given-names>
              </name>
              <name name-style="western">
                <surname>Burse</surname>
                <given-names>VW</given-names>
              </name>
              <name name-style="western">
                <surname>Bernert</surname>
                <given-names>JT</given-names>
                <suffix>Jr</suffix>
              </name>
              <name name-style="western">
                <surname>Henderson</surname>
                <given-names>LO</given-names>
              </name>
              <name name-style="western">
                <surname>Needham</surname>
                <given-names>LL</given-names>
              </name>
            </person-group>
            <year>1989</year>
            <article-title>Chlorinated hydrocarbon levels in human serum: effects of fasting and feeding.</article-title>
            <source>Arch Environ Contam Toxicol</source>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>495</fpage>
            <lpage>500</lpage>
          </citation>
        </ref>
        <ref id="r33">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Porta</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Malats</surname>
                <given-names>N</given-names>
              </name>
              <name name-style="western">
                <surname>Jariod</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Grimalt</surname>
                <given-names>JO</given-names>
              </name>
              <name name-style="western">
                <surname>Rifa</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Carrato</surname>
                <given-names>A</given-names>
              </name>
              <etal/>
            </person-group>
            <year>1999</year>
            <article-title>Serum concentrations of organochlorine compounds and K-<italic>ras</italic> mutations in exocrine pancreatic cancer. PANKRAS II Study Group.</article-title>
            <source>Lancet</source>
            <volume>354</volume>
            <issue>9196</issue>
            <fpage>2125</fpage>
            <lpage>2129</lpage>
          </citation>
        </ref>
        <ref id="r34">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Potter</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <year>1996</year>
            <article-title>Nutrition and colorectal cancer.</article-title>
            <source>Cancer Causes Control</source>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>127</fpage>
            <lpage>146</lpage>
          </citation>
        </ref>
        <ref id="r35">
          <citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Potter</surname><given-names>JD</given-names></name></person-group><year>1999</year><article-title>Colorectal cancer: molecules and populations.</article-title><source>J Natl Cancer Inst</source><volume>91</volume><issue>11</issue>): <fpage>916</fpage><lpage>932</lpage></citation>
        </ref>
        <ref id="r36">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Rothman</surname>
                <given-names>N</given-names>
              </name>
              <name name-style="western">
                <surname>Cantor</surname>
                <given-names>KP</given-names>
              </name>
              <name name-style="western">
                <surname>Blair</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Bush</surname>
                <given-names>D</given-names>
              </name>
              <name name-style="western">
                <surname>Brock</surname>
                <given-names>JW</given-names>
              </name>
              <name name-style="western">
                <surname>Helzlsouer</surname>
                <given-names>K</given-names>
              </name>
              <etal/>
            </person-group>
            <year>1997</year>
            <article-title>A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues.</article-title>
            <source>Lancet</source>
            <volume>350</volume>
            <issue>9073</issue>
            <fpage>240</fpage>
            <lpage>244</lpage>
          </citation>
        </ref>
        <ref id="r37">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Safe</surname>
                <given-names>S.</given-names>
              </name>
            </person-group>
            <year>1990</year>
            <article-title>Polychlorinated biphenyls (PCBs), dibenzo-<italic>p</italic>-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs).</article-title>
            <source>Crit Rev Toxicol</source>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>51</fpage>
            <lpage>88</lpage>
          </citation>
        </ref>
        <ref id="r38">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Schlummer</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Moser</surname>
                <given-names>GA</given-names>
              </name>
              <name name-style="western">
                <surname>McLachlan</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <year>1998</year>
            <article-title>Digestive tract absorption of PCDD/Fs, PCBs, and HCB in humans: mass balances and mechanistic considerations.</article-title>
            <source>Toxicol Appl Pharmacol</source>
            <volume>152</volume>
            <issue>1</issue>
            <fpage>128</fpage>
            <lpage>137</lpage>
          </citation>
        </ref>
        <ref id="r39">
          <citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Settimi</surname><given-names>L</given-names></name><name name-style="western"><surname>Comba</surname><given-names>P</given-names></name><name name-style="western"><surname>Bosia</surname><given-names>S</given-names></name><name name-style="western"><surname>Ciapini</surname><given-names>C</given-names></name><name name-style="western"><surname>Desideri</surname><given-names>E</given-names></name><name name-style="western"><surname>Fedi</surname><given-names>A</given-names></name></person-group>, etal. <year>2001</year><article-title>Cancer risk among male farmers: a multi-site case-control study.</article-title><source>Int J Occup Med Environ Health</source><volume>14</volume><issue>4</issue>): <fpage>339</fpage><lpage>347</lpage></citation>
        </ref>
        <ref id="r40">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Slebos</surname>
                <given-names>RJ</given-names>
              </name>
              <name name-style="western">
                <surname>Hoppin</surname>
                <given-names>JA</given-names>
              </name>
              <name name-style="western">
                <surname>Tolbert</surname>
                <given-names>PE</given-names>
              </name>
              <name name-style="western">
                <surname>Holly</surname>
                <given-names>EA</given-names>
              </name>
              <name name-style="western">
                <surname>Brock</surname>
                <given-names>JW</given-names>
              </name>
              <name name-style="western">
                <surname>Zhang</surname>
                <given-names>RH</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2000</year>
            <article-title>K-<italic>ras</italic> and <italic>p53</italic> in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study.</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <volume>9</volume>
            <issue>11</issue>
            <fpage>1223</fpage>
            <lpage>1232</lpage>
          </citation>
        </ref>
        <ref id="r41">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Soliman</surname>
                <given-names>AS</given-names>
              </name>
              <name name-style="western">
                <surname>Smith</surname>
                <given-names>MA</given-names>
              </name>
              <name name-style="western">
                <surname>Cooper</surname>
                <given-names>SP</given-names>
              </name>
              <name name-style="western">
                <surname>Ismail</surname>
                <given-names>K</given-names>
              </name>
              <name name-style="western">
                <surname>Khaled</surname>
                <given-names>H</given-names>
              </name>
              <name name-style="western">
                <surname>Ismail</surname>
                <given-names>S</given-names>
              </name>
              <etal/>
            </person-group>
            <year>1997</year>
            <article-title>Serum organochlorine pesticide levels in patients with colorectal cancer in Egypt.</article-title>
            <source>Arch Environ Health</source>
            <volume>52</volume>
            <issue>6</issue>
            <fpage>409</fpage>
            <lpage>415</lpage>
          </citation>
        </ref>
        <ref id="r42">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Tortola</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Marcuello</surname>
                <given-names>E</given-names>
              </name>
              <name name-style="western">
                <surname>Gonzalez</surname>
                <given-names>I</given-names>
              </name>
              <name name-style="western">
                <surname>Reyes</surname>
                <given-names>G</given-names>
              </name>
              <name name-style="western">
                <surname>Arribas</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Aiza</surname>
                <given-names>G</given-names>
              </name>
              <etal/>
            </person-group>
            <year>1999</year>
            <article-title><italic>p53</italic> and K-<italic>ras</italic> gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer.</article-title>
            <source>J Clin Oncol</source>
            <volume>17</volume>
            <issue>5</issue>
            <fpage>1375</fpage>
            <lpage>1381</lpage>
          </citation>
        </ref>
        <ref id="r43">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Van den Berg</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Birnbaum</surname>
                <given-names>L</given-names>
              </name>
              <name name-style="western">
                <surname>Bosveld</surname>
                <given-names>AT</given-names>
              </name>
              <name name-style="western">
                <surname>Brunstrom</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Cook</surname>
                <given-names>P</given-names>
              </name>
              <name name-style="western">
                <surname>Feeley</surname>
                <given-names>M</given-names>
              </name>
              <etal/>
            </person-group>
            <year>1998</year>
            <article-title>Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife.</article-title>
            <source>Environ Health Perspect</source>
            <volume>106</volume>
            <fpage>775</fpage>
            <lpage>792</lpage>
          </citation>
        </ref>
        <ref id="r44">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name name-style="western">
                <surname>Lewis-Michl</surname>
                <given-names>EL</given-names>
              </name>
              <name name-style="western">
                <surname>Hwang</surname>
                <given-names>SA</given-names>
              </name>
              <name name-style="western">
                <surname>Fitzgerald</surname>
                <given-names>EF</given-names>
              </name>
              <name name-style="western">
                <surname>Stark</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <year>2002</year>
            <article-title>Cancer incidence among a cohort of female farm residents in New York State.</article-title>
            <source>Arch Environ Health</source>
            <volume>57</volume>
            <issue>6</issue>
            <fpage>561</fpage>
            <lpage>567</lpage>
          </citation>
        </ref>
        <ref id="r45">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Wilkinson</surname>
                <given-names>P</given-names>
              </name>
              <name name-style="western">
                <surname>Thakrar</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Shaddick</surname>
                <given-names>G</given-names>
              </name>
              <name name-style="western">
                <surname>Stevenson</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Pattenden</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Landon</surname>
                <given-names>M</given-names>
              </name>
              <etal/>
            </person-group>
            <year>1997</year>
            <article-title>Cancer incidence and mortality around the Pan Britannica Industries pesticide factory, Waltham Abbey.</article-title>
            <source>Occup Environ Med</source>
            <volume>54</volume>
            <issue>2</issue>
            <fpage>101</fpage>
            <lpage>107</lpage>
          </citation>
        </ref>
      </ref-list>
    </back>
  </article>
</PAPER>